Literature DB >> 11700312

Misexpression of the eyes absent family triggers the apoptotic program.

S Wesley Clark1, Brian E Fee, John L Cleveland.   

Abstract

Genetic studies in Drosophila and mice have shown that eyes absent (eya) is an important and conserved transcriptional regulator of development. Along with eyeless/Pax6, sine oculis, and dachshund, eya genes function as master regulators in eye development and can induce ectopic eye formation. Furthermore, the loss-of-function mutants of these genes in the fly causes partial or complete loss of the compound eye, and this is associated with inappropriate apoptosis. Conversely, ectopic eyeless expression in the context of eyes absent or sine oculis mutations results in apoptosis, suggesting that the proper ratio of these factors regulates apoptosis. Here we report that enforced expression of fly eya or of one of its mammalian homologs, Eya2, triggers rapid apoptosis in interleukin-3-dependent 32D.3 murine myeloid cells, which express Eya family members but not Pax6. Eya-induced cell death overrides survival factors and has many features typical of apoptosis, including plasma and mitochondrial membrane changes and caspase activation. Eya-induced apoptosis is blocked by Bcl-2 overexpression but not by the broad-spectrum caspase inhibitor z-VAD.fmk, suggesting that mitochondria are a major target in Eya-induced apoptosis. These results support the concept that inappropriate changes in the steady state levels of Eya proteins may trigger programmed cell deaths during development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700312     DOI: 10.1074/jbc.M108410200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

Review 2.  The SIX1-EYA transcriptional complex as a therapeutic target in cancer.

Authors:  Melanie A Blevins; Christina G Towers; Aaron N Patrick; Rui Zhao; Heide L Ford
Journal:  Expert Opin Ther Targets       Date:  2015-01-02       Impact factor: 6.902

3.  Eya2, a Target Activated by Plzf, Is Critical for PLZF-RARA-Induced Leukemogenesis.

Authors:  Ryoichi Ono; Masahiro Masuya; Satomi Ishii; Naoyuki Katayama; Tetsuya Nosaka
Journal:  Mol Cell Biol       Date:  2017-06-15       Impact factor: 4.272

4.  Six and Eya promote apoptosis through direct transcriptional activation of the proapoptotic BH3-only gene egl-1 in Caenorhabditis elegans.

Authors:  Takashi Hirose; Brendan D Galvin; H Robert Horvitz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

5.  Drosophila nemo promotes eye specification directed by the retinal determination gene network.

Authors:  Lorena R Braid; Esther M Verheyen
Journal:  Genetics       Date:  2008-08-30       Impact factor: 4.562

6.  Genome-wide analysis of survival in early-stage non-small-cell lung cancer.

Authors:  Yen-Tsung Huang; Rebecca S Heist; Lucian R Chirieac; Xihong Lin; Vidar Skaug; Shanbeh Zienolddiny; Aage Haugen; Michael C Wu; Zhaoxi Wang; Li Su; Kofi Asomaning; David C Christiani
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

7.  Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection.

Authors:  Philipp Schatz; Jürgen Distler; Kurt Berlin; Matthias Schuster
Journal:  Nucleic Acids Res       Date:  2006-05-02       Impact factor: 16.971

8.  EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.

Authors:  I M Wilson; E A Vucic; K S S Enfield; K L Thu; Y A Zhang; R Chari; W W Lockwood; N Radulovich; D T Starczynowski; J P Banáth; M Zhang; A Pusic; M Fuller; K M Lonergan; D Rowbotham; J Yee; J C English; T P H Buys; S A Selamat; I A Laird-Offringa; P Liu; M Anderson; M You; M S Tsao; C J Brown; K L Bennewith; C E MacAulay; A Karsan; A F Gazdar; S Lam; W L Lam
Journal:  Oncogene       Date:  2013-10-07       Impact factor: 9.867

9.  Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.

Authors:  Audrey Vincent; Seung-Mo Hong; Chaoxin Hu; Noriyuki Omura; Angela Young; Haeryoung Kim; Jun Yu; Spencer Knight; Michael Ayars; Margaret Griffith; Isabelle Van Seuningen; Anirban Maitra; Michael Goggins
Journal:  Oncotarget       Date:  2014-05-15

10.  Identification of I411K, a novel missense EYA4 mutation causing autosomal dominant non‑syndromic hearing loss.

Authors:  Minxing Tan; Xiaofei Shen; Jun Yao; Qinjun Wei; Yajie Lu; Xin Cao; Guangqian Xing
Journal:  Int J Mol Med       Date:  2014-09-19       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.